Virus-driven dysregulation of the BCR pathway: a potential mechanism for the high prevalence of HIV related B-cell lymphoma
- 28 August 2024
- journal article
- review article
- Published by Springer Nature in Annals of Hematology
- Vol. 103 (12) , 4839-4849
Abstract
In people living with HIV (PLWH), the susceptibility to malignancies is notably augmented, with lymphoma emerging as a predominant malignancy. Even in the antiretroviral therapy (ART) era, aggressive B-cell lymphoma stands out as a paramount concern. Yet, the pathogenesis of HIV related lymphoma (HRL) largely remains an enigma. Recent insights underscore the pivotal role of the dysregulated B cell receptor (BCR) signaling cascade, evidencing its oncogenic potential across a spectrum of lymphomas. Intricate interplays between HIV and BCR structural-functional integrity have been identified in PLWH. In this review, we elucidated the mechanism by which the BCR signaling pathway is involved in HRL, mainly including the following aspects: HIV can reshape BCR structure by modulating of activation-induced cytidine deaminase (AID) and recombination-activating gene (RAG) dynamics; HIV can act as a chronic antigen to activate the BCR signaling pathway, such as upregulating PI3K and MAPK signaling pathway and reducing the expression of CD300a; HIV co-infection with other oncogenic viruses may also influence tumor formation mediated by the BCR signaling pathway. This review aims to elucidate the intricate regulation of the BCR signaling pathway by HIV in B cell lymphoma, providing a novel perspective on the pathogenesis of lymphoma in HIV-affected environments.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (7222095)
This publication has 109 references indexed in Scilit:
- Binding of Hepatitis C Virus to CD81Science, 1998
- Epstein-Barr Virus LMP2A Drives B Cell Development and Survival in the Absence of Normal B Cell Receptor SignalsImmunity, 1998
- Activation of a Ras–MAPK-Dependent Pathway by Epstein–Barr Virus Latent Membrane Protein 1 Is Essential for Cellular TransformationVirology, 1998
- A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic CellsJournal of Experimental Medicine, 1997
- Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based LymphomasNew England Journal of Medicine, 1995
- The CD19/CR2/TAPA-1 Complex of B Lymphocytes: Linking Natural to Acquired ImmunityAnnual Review of Immunology, 1995
- Immunoglobulin V H 3 Gene Products: Natural Ligands for HIV gp120Science, 1993
- Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma.1993
- CD19: Lowering the Threshold for Antigen Receptor Stimulation of B LymphocytesScience, 1992
- RAG-1 and RAG-2, Adjacent Genes That Synergistically Activate V(D)J RecombinationScience, 1990